Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 607 across all filing types
Latest filing 2022-04-25 Regulatory Filings
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document is very short (1911 characters) and contains the header 'RNS Number : 1839J' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security's auction call period. This is a short, specific regulatory update that does not fit the criteria for a full report (like 10-K or IR) or a specific corporate action (like DIV or CAP). Given the explicit mention of RNS and the nature of the announcement (a routine market operation update), the most appropriate classification is the general regulatory announcement fallback category.
2022-04-25 English
Price Monitoring Extension
Report Publication Announcement Classification · 1% confidence The document is very short (1911 characters) and contains the header 'RNS Number : 7845I'. It announces a 'Price Monitoring Extension' for a security, which is a specific, short-form operational update related to trading on the London Stock Exchange. It explicitly mentions RNS (the news service of the London Stock Exchange) and its role as a Primary Information Provider. This type of brief, operational regulatory announcement that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing, which corresponds to the RNS code.
2022-04-20 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1928 characters) and contains the header 'RNS Number : 8565H'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a specific, time-sensitive regulatory announcement that does not fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder votes (DVA). Since it is a direct announcement disseminated via the RNS system and concerns market operations rather than a standard financial disclosure, it best fits the general 'Regulatory Filings' category, which serves as a fallback for miscellaneous regulatory announcements.
2022-04-08 English
Price Monitoring Extension
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 8544H' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a specific operational update related to trading mechanisms. This type of short, specific regulatory announcement that doesn't fit into core financial reporting categories (like 10-K, ER, IR) is best classified under the general regulatory announcement category, RNS. The document length is very short (1911 chars), supporting the idea that it is an announcement rather than a full report.
2022-04-08 English
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is a formal notification released via RNS (RNS Number : 2148H) on April 4, 2022. The content explicitly details 'Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them' (PDMRs). It specifically reports the grant of options and the subsequent exercise and sale of shares by the CFO Designate and the outgoing CFO. This type of insider transaction disclosure, often mandated by regulations like MAR (Market Abuse Regulation, referenced in the text), falls under the category of Director's Dealing or insider trading reports. The closest matching category is 'Director's Dealing' (DIRS).
2022-04-04 English
Second Price Monitoring Extn
Regulatory Filings Classification · 1% confidence The document is very short (1928 chars) and contains the header 'RNS Number : 1453H'. It announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. This is a specific, immediate regulatory announcement concerning trading mechanics rather than a comprehensive financial report (like 10-K or IR) or a general corporate action. Since it is a direct announcement disseminated via the RNS system and doesn't fit into the more specific categories like DIV, DIRS, or ER, it falls best under the general 'Regulatory Filings' category, which serves as the fallback for miscellaneous regulatory announcements.
2022-04-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.